PharmaBiome

@BaseLaunch finances @PharmaBiome AG! We are proud to receive this prestigious grant and are eager to turn our learnings from this great program into action. #baselaunch #microbiome #therapy #innovation #startups

Check out mako, a new cool software tool from @Karoline_Faust and Lisa Röttjers that converts microbiome data and networks into a graph database and visualizes query results, allowing to carry out network-based queries. nature.com/articles/s4159…

You wouldn’t believe what I just saw. More images and video to come... #MarsHelicopter go.nasa.gov/ingenuity

@pharmabiome announces the election of Dr. Thomas Meier as Chairman of the Board and Dr. Patrik Forrer as a further new Board member. The Company successfully raised CHF 1.75 million new capital to bridge to a planned Series A financing. pharmabiome.com/about-us/press…

Our pioneering efforts are awarded a price! @pharmabiome is proud to be a finalist of the ZKB Pionierpreis 2020. Our congratulations go to @microcapsAG, the winner and fellow ETH-SpinOff. Don’t forget to vote for us at the TOP 100 Swiss startup award! bit.ly/2T1yep8

@pharmabiome in the news - the @tagesanzeiger interviewed our founders Tomas de Wouters and Gerhard Rogler on our novel approach to microbiome therapy. tagesanzeiger.ch/wissen/medizin… #news #microbiome #therapy #innovation #startups

After a successful Microbiome Movement Drug Development 2020 in London with several contributions from our CEO Tomas de Wouters, we are looking forward to meeting you next week at the 13th European Life Sciences CEO Forum! #sachs_ELSF #MMDD #microbiome #therapy #innovation

@tdewouters CEO of @pharmabiome at the panel discussion #microbiomemvnt

Microbiome leadership panel discussion on current strategies on how to take microbiome therapy to market #microbiomemvnt #fmt #microbiome

Tomas de Wouters @pharmabiome kicks off the Pre-Clincial stream with new insights on the design and development of complex consortia that treat disease #microbiome #MicrobiomeMVNT

Join @pharmabiome at Life Science Zurich Impact on February the 3rd! Our CEO @tdewouters will present in the Personalized and Participatory Health session. We are looking forward to exchanging with you! lnkd.in/gsznWq8 #LSZIMPACT #microbiome #innovation #startups

BaseLaunch is wishing you a great '20 start & with it we have some news! We shared companies under review to advance in the program previously. Congrats to the selected: @pharmabiome, Synoesis, TOLREMO, and one in stealth mode. Full portfolio here: baselaunch.ch/portfolio/

@BaseLaunch finances @pharmabiome AG! We are proud to receive this prestigious grant and are eager to turn our learnings from this great program into action. #baselaunch #microbiome #therapy #innovation #startups

The new year brings good news - @pharmabiome is among the Top Ten startups selected for the ZKB Pionierpreis 2020! We are looking forward to presenting at the final ceremony on the 22nd of April! #pionierpreis #microbiome #therapy #innovation #startups lnkd.in/gi3WyRr

ZKB Pionierpreis Technopark: Zehn Firmen kämpfen um 100‘000 Franken Startupticker.ch | The Swiss Startup News channel startupticker.ch/en/news/januar…

Joining @biodataworld Congress in Basel next two days? Visit us in the Startup Village at Booth 46. Happy to chat about @microbiome related diseases and the products in our pipeline to treat them.

We had a great #IndustryDay with interesting interactions and discussions! Thank you to ETH Zürich #eth_en #eth for this great platform. #pharmabiome

#pharmabiome among the TOP 100 Swiss startups #TOP100SSU for the 4th year in a row! We are very proud of our continued presence and active contribution to the Swiss Startup ecosystem – and of course, to wear the Top 100 label. lnkd.in/dY7ejaQ

Final day. Support your favorite Swiss startup in the TOP 100 Swiss Startup Award's public vote. bit.ly/2ZlY4W3 Voting closes tonight! #top100SSU

Fecal microbiota transplantation. It can save people's lives, as summarized so nicely here: justinedees.com/2019/06/13/cou… But also -- it has risks. News today that an immunocompromised person has died after drug-resistant bacteria were transferred through FMT. cnbc.com/2019/06/13/fda…